previous compound ID: 1785 next compound
InChIKey: PYZRQGJRPPTADH-UHFFFAOYSA-N
SMILES: C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "R Robert" "DY Thomas" "D Rotin" "B Kus" "J Liao" "E Matthes" "GW Carlile" "J Goepp" "SD Macknight"

chemical graph of compound 1785





CID is 3878
synonyms found at PubChem are:
lamotrigine, 84057-84-1, 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, Lamictal, Lamictal Cd, Lamotrigina, Lamotriginum, Lamictal XR, Lamotriginum [Latin], Lamotrigina [Spanish], Lamictal ODT, BW-430C, Labileno, Lamiktal, Lamitor, BW 430C, 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine, Lamictin, 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-, 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine, Lamictal (TN), UNII-U3H27498KS, Lamotrigine [USAN:INN:BAN], EINECS 281-901-8, CHEMBL741, C9H7Cl2N5, GW 273293, Lamotrigine (JAN/USAN/INN), MLS000069685, CHEBI:6367, PYZRQGJRPPTADH-UHFFFAOYSA-N, U3H27498KS, EUR-1048, GI 267119X, NCGC00015605-06, SMR000058464, DSSTox_CID_3195, L 3791, DSSTox_RID_76918, DSSTox_GSID_23195, Crisomet, CAS-84057-84-1, SR-01000000187, lamitrin, lamotrigin, BW430C, HSDB 7526, Lamictin (TN), Lamotrigine [USAN:USP:INN:BAN], Opera_ID_12, Tocris-1611, hydroxymethyl progesterone, AC1L1GWT, Lopac-L-3791, Faes Brand of Lamotrigine, D03FLC, Juste Brand of Lamotrigine, Desitin Brand of Lamotrigine, Lopac0_000688, SCHEMBL35439, MLS000759486, MLS001077325, MLS001423991, BIDD:GT0794, Lamotrigine, >=98%, powder, GTPL2622, TRI020, DTXSID2023195, CTK8B4406, KS-00000XIV, ZINC13156, MolPort-003-666-744, HMS2051C10, HMS2089M08, HMS2093P21, HMS2230L04, HMS3262I17, HMS3268G17, HMS3371O16, HMS3393C10, HMS3657A17, HMS3715H21, Pharmakon1600-01505610, BCP12156, Glaxo Wellcome Brand of Lamotrigine, HY-B0495, Lamotrigine 1.0 mg/ml in Methanol, GlaxoSmithKline Brand of Lamotrigine, Tox21_110179, Tox21_500688, ANW-44921, BDBM50031299, MFCD00865333, NSC746307, NSC759171, s3024, STK628377, AKOS005561147, Tox21_110179_1, 6-(2,2,4-triazine-3,5-diyldiamine, CCG-100856, CS-2616, DB00555, KS-1074, LP00688, MCULE-7648410888, NC00106, NE61394, NSC-746307, NSC-759171, SMP2_000303, NCGC00015605-01, NCGC00015605-02, NCGC00015605-03, NCGC00015605-04, NCGC00015605-05, NCGC00015605-07, NCGC00015605-08, NCGC00015605-09, NCGC00015605-10, NCGC00022936-02, NCGC00022936-04, NCGC00022936-05, NCGC00261373-01, AC-10298, AJ-08354, AN-35947, AT-15488, BC200572, BR-72807, CPD000058464, K499, SAM001246697, SC-12025, SBI-0050666.P002, AB0014255, LS-155249, TR-026049, B2249, EU-0100688, FT-0602546, L0241, ST24024203, 57L841, D00354, J10032, AB00384359-16, AB00384359_17, AB00384359_18, A840709, 3,5-diamino-(2,3-dichlorophenyl)-1,2,4-triazine, 3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine, Q-201221, SR-01000000187-2, SR-01000000187-4, SR-01000000187-7, BRD-K93460210-071-01-6, SR-01000000187-10, 3,5-diamino-6-(2,3,-dichlorophenyl)-1,2,4-triazine, F2173-0540, Z1550648755, 6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine, 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine, 6-[2,3-bis(chloranyl)phenyl]-1,2,4-triazine-3,5-diamine, Lamotrigine, European Pharmacopoeia (EP) Reference Standard, 6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine(lamotrigine), GI 267119X; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, Lamotrigine, United States Pharmacopeia (USP) Reference Standard, Lamotrigine, Pharmaceutical Secondary Standard; Certified Reference Material, Lamotrigine for peak identification, European Pharmacopoeia (EP) Reference Standard, Lamotrigine for system suitability, European Pharmacopoeia (EP) Reference Standard